ArticleCardiology and therapy2025

An External Control Arm for the Oral Factor XIa Inhibitor Asundexian Phase 2 Trial in Atrial Fibrillation (PACIFIC-AF) Using Electronic Health Records.

Tatsiana Vaitsiakhovich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.